AW
IBRX icon

Avion Wealth’s ImmunityBio IBRX Stock Holding History

Avion Wealth’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Sell
666
-200
-23% -$1.51K ﹤0.01% 793
2026
Q1 		$6K Hold
866
– – ﹤0.01% 611
2025
Q4 		$1K Hold
866
– – ﹤0.01% 1047
2025
Q3 		$2K Sell
866
-353
-29% -$909 ﹤0.01% 859
2025
Q2 		$3K Buy
1,219
+353
+41% +$949 ﹤0.01% 725
2025
Q1 		$2K Hold
866
– – ﹤0.01% 720
2024
Q4 		$2K Hold
866
– – ﹤0.01% 717
2024
Q3 		$3K Hold
866
– – ﹤0.01% 612
2024
Q2 		$5K Sell
866
-62
-7% -$409 ﹤0.01% 462
2024
Q1 		$5K Sell
928
-109
-11% -$494 ﹤0.01% 461
2023
Q4 		$5K Buy
1,037
+341
+49% +$1.07K ﹤0.01% 398
2023
Q3 		$1K Buy
+696
New +$1.4K ﹤0.01% 653

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avion Wealth's IBRX Position: Q2 2026 in Review

Avion Wealth reduced its ImmunityBio (IBRX) stake by 23% in Q2 2026, selling an estimated $1.51K and leaving 666 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Avion Wealth first reported a position in IBRX in Q3 2023 and has held it in 12 quarters since. The position peaked at $6K in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Avion Wealth held 666 shares of ImmunityBio worth $5K as of Q2 2026.
  • Avion Wealth sold 200 ImmunityBio shares in Q2 2026, an estimated $1.51K.
  • ImmunityBio made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #793 holding.
  • Avion Wealth first reported a position in ImmunityBio in Q3 2023 and has held it in 12 quarters since.
  • Avion Wealth's ImmunityBio position peaked at $6K in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.